Tumor microenvironment: recent advances in understanding and its role in modulating cancer therapies
Medical Oncology · vol. 42 (4) · 117-117
المخرجات
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
609 output
Medical Oncology · vol. 42 (4) · 117-117
Frontiers in Microbiology · vol. 16 · 1549044-1549044
Antimicrobial resistance (AMR) is recognized as one of the foremost global health challenges, complicating the treatment of infectious diseases and contributing to increased morbidity and mortality rates. Traditionally, microbiological culture and susceptibility testing methods, such as disk diffusion and minimum inhibitory concentration (MIC) assays, have been employed to identify AMR bacteria. However, these conventional techniques are often labor intensive and time consuming and lack the requisite sensitivity for the early detection of resistance. Recent advancements in molecular and genomic technologies-such as next-generation sequencing (NGS), matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS), lateral flow immunoassays (LFIAs), PCR-based diagnostic methods, and CRISPR-based diagnostics-have revolutionized the diagnosis of AMR. These innovative approaches provide increased sensitivity, reduced turnaround times, and the ability to identify genetic resistance mechanisms. This review seeks to examine the advantages and disadvantages of both emerging technologies and traditional methods for detecting AMR, emphasizing the potential benefits and limitations inherent to each. By understanding the strengths and limitations of these technologies, stakeholders, including researchers, healthcare professionals, regulatory agencies, health authorities, financial managers, and patients, can make informed decisions aimed at preventing the emergence and dissemination of antibiotic-resistant strains, thereby ultimately increasing patient safety.
BMC Nursing · vol. 24 (1) · 386-386
BACKGROUND: Neonatal nurses in high-risk Neonatal Intensive Care Units (NICUs) navigate complex, time-sensitive clinical decisions where accuracy and judgment are critical. Generative artificial intelligence (AI) has emerged as a supportive tool, yet its integration raises concerns about its impact on nurses' decision-making, professional autonomy, and organizational workflows. AIM: This study explored how neonatal nurses experience and integrate generative AI in clinical decision-making, examining its influence on nursing practice, organizational dynamics, and cultural adaptation in Saudi Arabian NICUs. METHODS: An interpretive phenomenological approach, guided by Complexity Science, Normalization Process Theory, and Tanner's Clinical Judgment Model, was employed. A purposive sample of 33 neonatal nurses participated in semi-structured interviews and focus groups. Thematic analysis was used to code and interpret data, supported by an inter-rater reliability of 0.88. Simple frequency counts were included to illustrate the prevalence of themes but were not used as quantitative measures. Trustworthiness was ensured through reflexive journaling, peer debriefing, and member checking. RESULTS: Five themes emerged: (1) Clinical Decision-Making, where 93.9% of nurses reported that AI-enhanced judgment but required human validation; (2) Professional Practice Transformation, with 84.8% noting evolving role boundaries and workflow changes; (3) Organizational Factors, as 97.0% emphasized the necessity of infrastructure, training, and policy integration; (4) Cultural Influences, with 87.9% highlighting AI's alignment with family-centered care; and (5) Implementation Challenges, where 90.9% identified technical barriers and adaptation strategies. CONCLUSIONS: Generative AI can support neonatal nurses in clinical decision-making, but its effectiveness depends on structured training, reliable infrastructure, and culturally sensitive implementation. These findings provide evidence-based insights for policymakers and healthcare leaders to ensure AI integration enhances nursing expertise while maintaining safe, patient-centered care.
Scientific Reports · vol. 15 (1) · 16518-16518
People of all demographics are impacted by mental illness, which has become a widespread and international health problem. Effective treatment and support for mental illnesses depend on early discovery and precise diagnosis. Notably, delayed diagnosis may lead to suicidal thoughts, destructive behaviour, and death. Manual diagnosis is time-consuming and laborious. With the advent of AI, this research aims to develop a novel mental health disorder detection network with the objective of maximum accuracy and early discovery. For this reason, this study presents a novel framework for the early detection of mental illness disorders using a multi-modal approach combining speech and behavioral data. This framework preprocesses and analyzes two distinct datasets to handle missing values, normalize data, and eliminate outliers. The proposed NeuroVibeNet combines Improved Random Forest (IRF) and Light Gradient-Boosting Machine (LightGBM) for behavioral data and Hybrid Support Vector Machine (SVM) and K-Nearest Neighbors (KNN) for voice data. Finally, a weighted voting mechanism is applied to consolidate predictions. The proposed model achieves robust performance and a competitive accuracy of 99.06% in distinguishing normal and pathological conditions. This framework validates the feasibility of multi-modal data integration for reliable and early mental illness detection.
PLoS ONE · vol. 20 (1) · e0310218-e0310218
Diabetes, a chronic condition affecting millions worldwide, necessitates early intervention to prevent severe complications. While accurately predicting diabetes onset or progression remains challenging due to complex and imbalanced datasets, recent advancements in machine learning offer potential solutions. Traditional prediction models, often limited by default parameters, have been superseded by more sophisticated approaches. Leveraging Bayesian optimization to fine-tune XGBoost, researchers can harness the power of complex data analysis to improve predictive accuracy. By identifying key factors influencing diabetes risk, personalized prevention strategies can be developed, ultimately enhancing patient outcomes. Successful implementation requires meticulous data management, stringent ethical considerations, and seamless integration into healthcare systems. This study focused on optimizing the hyperparameters of an XGBoost ensemble machine learning model using Bayesian optimization. Compared to grid search XGBoost (accuracy: 97.24%, F1-score: 95.72%, MCC: 81.02%), the XGBoost with Bayesian optimization achieved slightly improved performance (accuracy: 97.26%, F1-score: 95.72%, MCC:81.18%). Although the improvements observed in this study are modest, the optimized XGBoost model with Bayesian optimization represents a promising step towards revolutionizing diabetes prevention and treatment. This approach holds significant potential to improve outcomes for individuals at risk of developing diabetes.
IEEE Transactions on Consumer Electronics · vol. 71 (2) · 4771-4779
The satellite Internet of Things (IoT), utilizing Cyber-Physical Systems (CPS) Communication Networks and various satellite-borne and ground-based terminal devices, enables integrated human-object connectivity and information exchange across space, sky, and ground. A terminal authentication method based on trust evaluation is proposed to ensure the secure and efficient utilization of satellite IoT resources. This method optimizes authentication strategies by evaluating the trustworthiness of terminal devices. A satellite IoT terminal trust evaluation mechanism is proposed for scenarios where a previously strongly authenticated terminal needs re-authentication within a short time or where trust is granted via a strongly authenticated node. This mechanism describes dynamically adjusted trust metrics and evaluation models based on direct and indirect trust. A satellite IoT access authentication protocol based on trust evaluation is also designed, employing corresponding authentication mechanisms according to the device’s trust level. This simplifies the re-authentication process for highly trusted devices, enabling differentiated authentication services for various terminal devices within the same authentication framework. A comprehensive security analysis of the protocol is conducted using informal methods and the Tamarin formal verification tool. Experiments validate the protocol’s effectiveness, showing that it can reduce overall authentication costs and streamline the authentication process through trust-based simplifications.
Food Science & Nutrition · vol. 13 (1) · e4682-e4682
Luteolin is widely distributed phytochemical, a flavonoid, in kingdom plantae. Luteolin with potential antioxidant activity prevent ROS-induced damages and reduce oxidative stress which is mainly responsible in pathogenesis of many diseases. Several chemo preventive activities and therapeutic benefits are associated with luteolin. Luteolin prevents cancer via modulation of numerous pathways, that is, by inactivating proteins; such as procaspase-9, CDC2 and cyclin B or upregulation of caspase-9 and caspase-3, cytochrome C, cyclin A, CDK2, and APAF-1, in turn inducing cell cycle arrest as well as apoptosis. It also enhances phosphorylation of p53 and expression level of p53-targeted downstream gene. By Increasing BAX protein expression; decreasing VEGF and Bcl-2 expression it can initiate cell cycle arrest and apoptosis. Luteolin can stimulate mitochondrial-modulated functions to cause cellular death. It can also reduce expression levels of p-Akt, p-EGFR, p-Erk1/2, and p-STAT3. Luteolin plays positive role against cardiovascular disorders by improving cardiac function, decreasing the release of inflammatory cytokines and cardiac enzymes, prevention of cardiac fibrosis and hypertrophy; enhances level of CTGF, TGFβ1, ANP, Nox2, Nox4 gene expressions. Meanwhile suppresses TGFβ1 expression and phosphorylation of JNK. Luteolin helps fight diabetes via inhibition of alpha-glucosidase and ChE activity. It can reduce activity levels of catalase, superoxide dismutase, and GS4. It can improve blood glucose, insulin, HOMA-IR, and HbA1c levels. This review is an attempt to elaborate molecular targets of luteolin and its role in modulating irregularities in cellular pathways to overcome severe outcomes during diseases including cancer, cardiovascular disorders, diabetes, obesity, inflammation, Alzheimer's disease, Parkinson's disease, hepatic disorders, renal disorders, brain injury, and asthma. As luteolin has enormous therapeutic benefits, it could be a potential candidate in future drug development strategies.
BMC Nursing · vol. 24 (1) · 395-395
BACKGROUND: Workplace violence (WPV) remains a formidable concern among nurses worldwide, with up to 60% in Saudi Arabia reportedly experiencing some form of aggression. In tertiary care hospitals, robust hierarchies and cultural norms intensify underreporting, thwarting evidence-based prevention and obscuring vital data. AIM: This qualitative study investigated the perceived barriers to WPV reporting among nurses in tertiary care settings in the Aljouf region of Saudi Arabia, specifically addressing how organizational and cultural factors converge to discourage formal incident reporting. METHODS: A qualitative descriptive design was employed, guided by Ajzen's Theory of Planned Behavior and the Social Ecological Model. Thirty-six registered nurses, purposively sampled from three tertiary hospitals, participated in six semi-structured focus groups conducted in Arabic or English, depending on participant preference. Data were thematically analyzed in NVivo, with methodological rigor ensured through triangulation and inter-coder reliability. RESULTS: Three principal themes emerged: (1) Emotional and Psychological Barriers (78%), encompassing distress, anxiety, and fears of professional blame; (2) Organizational Ineffectiveness (65%), marked by convoluted reporting processes and perceived managerial indifference; and (3) Cultural and Hierarchical Influences (57%), reflecting deference to authority and normalization of violence. These themes illustrate how attitudes, subjective norms, and perceived behavioral control shaped by socio-cultural dynamics collectively contribute to persistent underreporting. CONCLUSIONS: Mitigating WPV underreporting in Saudi tertiary care hospitals requires streamlined, user-friendly reporting channels, leadership accountability, and holistic psychosocial support. Implementing interprofessional education aimed at dismantling hierarchical imbalances can foster a zero-tolerance ethos toward violence. Longitudinal and comparative research should further examine evolving reporting behaviors to refine context-specific, culturally attuned strategies for addressing WPV. CLINICAL TRIAL NUMBER: Not applicable.
Food Science & Nutrition · vol. 13 (5) · e70164-e70164
ABSTRACT Anthocyanins (Anthos; flower and kyanos; blue) are natural coloring compounds from the flavonoids class that include cyanidin, peonidin, delphinidin, malvidin, pelargonidin, and petunidin. Recently, the role of anthocyanins in disease prevention, especially inflammation, diabetes, cancer, neuro‐disorders, hepato‐renal protective, and immuno‐modulation properties has been highlighted. The current review covered the literature on the pharmacokinetics and pharmacological effects of anthocyanins, especially absorption, distribution, metabolism, and excretion (ADME). The discussion on molecular mechanisms underlying their therapeutic effects is the limelight of the article. The GLUT1, GLUT3, SGLT1, SMCT1, and SMCT2 are the main carriers involved in the transportation of anthocyanins in the gastrointestinal tract. The anthocyanins exert their anticancer effects by reducing the expression of IL‐6, IL‐1β, TNF‐β, COX‐2, downregulation of NF‐kB, EZH2, MDR1, Akt , and modulation of P13K/AKT and AMPK/mTOR pathways. The reduction in α‐amylase and α‐glucosidase and improved FFAR1 activity results in antidiabetic effects. The regulation of PGC‐1α/NRF2/TFAM, p‐PI3K/Akt/GSK3β, and Nrf2/HO‐1 prevents neurodegeneration. The anthocyanins impose hepato‐renal protective effects via ameliorating NLRP3 inflammasome, inhibiting MDA, GSSG, iNOS, HO‐1, ICAM‐1, β2‐microglobulin, and MPO activity, and improved SOD, CAT, and GSH activity. Anthocyanins promote beneficial gut microbiota and enhance SCFA production, thus inhibiting pro‐inflammatory markers. The immuno‐modulatory impact of anthocyanins involves the reduction of CRP, P‐selectin, C1q, and C4. Anthocyanins reduce LDL, VLDL, TGs, and TC via improved GBA and upregulation of ATP6 V0C, ZO‐1, and ATG4D expression. The WHO/FAO suggested that 2.5 mg/kg/day of grape‐skin extracts of anthocyanins are safe, and China recommended that 50 mg/day of anthocyanins are safe for consumption. In a nutshell, the multifaceted health benefits of anthocyanins make them promising candidates for disease prevention and therapeutic interventions.
Food Science & Nutrition · vol. 13 (7) · e70608-e70608
The continuous progression of cancerous severity due to the interaction of physical (ultraviolet radiation), chemical (smoking, mycotoxins, and heavy metals), and biological (microbial populations) carcinogens inspired scientists to develop a correlation between active therapeutic agents and cancer proliferation. This review highlights the molecular mechanism by which lycopene imparts its anticancerous role, focusing on clinical and animal trials to validate its effectiveness. The antioxidant profile of lycopene promotes anticancerous properties that reduce cancer prevalence by activating cell signaling pathways and gene expression (involved in cancer cell proliferation). Lycopene's anti-inflammatory properties suppresses the tumor growth and development-promoting pathways, such as the PI3K/Akt/mTOR pathway. The anticancer property of lycopene is also evidenced by its inhibitory potential of the Wnt/β-catenin signaling pathway that is involved in cancer cell modulation and propagation. Lycopene also suppresses and neutralizes oxidative stress and reactive oxygen species (ROS)-induced DNA damage, preventing gene mutation. Inflammation-induced cell death is mitigated by lycopene's anti-inflammatory potential that lowers the expression of interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Several clinical and randomized control trials have revealed the effect of lycopene supplementation in the management of cancer, including breast cancer, pancreatic cancer, prostate cancer, colon cancer, ovarian cancer, skin cancer, oral cancer, liver cancer, gastric cancer, and kidney cancer, by lessening prostate-specific antigen (PSA) levels. These studies also accentuate certain limitations that need further trials to evaluate the long-term consequences of lycopene supplementations and their specific effective dose.
Journal of Environmental Management · vol. 389 · 126170-126170
Scientific Reports · vol. 15 (1) · 28050-28050
The Internet of Things (IoT) consists of physical objects and devices embedded with network connectivity, software, and sensors to collect and transmit data. The development of the Internet of Things (IoT) has led to various security and privacy issues, including distributed denial-of-service (DDoS) attacks. Conventional attack detection methods face significant challenges related to privacy, scalability, and adaptability due to the dynamic nature of IoT environments. To address these limitations, this research proposes GraphFedAI, a novel framework that integrates adaptive session-based graph modeling, Pearson correlation-guided feature selection, interpolation-aware graph neural network (GNN) training, and federated learning to enable robust, scalable, and privacy-preserving DDoS detection in heterogeneous Internet of Things (IoT) networks.The framework represents the IoT network as dynamic graphs where communication patterns among devices are modeled as edges that evolve over time. Graph neural networks are utilized to extract both temporal and structural features from these graphs, thereby enhancing the accuracy of DDoS detection. Federated learning is incorporated to maintain data privacy by training models locally on each device without sharing raw data. This integration also ensures system scalability, as FL adapts training based on localized network topology.The system is evaluated using the CIC-IoT-2023 dataset, demonstrating its effectiveness in achieving high detection accuracy, low false positive rates, and strong resilience under dynamic IoT conditions.
Comprehensive Reviews in Food Science and Food Safety · vol. 24 (4) · e70215-e70215
Carboxymethyl cellulose (CMC) is a leading hydrocolloid for biodegradable packaging films and edible coatings due to its film-forming ability, biodegradability, and nontoxicity. However, its application is limited by moisture sensitivity, poor mechanical strength, flammability, and inadequate gas barrier properties. This review explores the formulation, structural properties, and practical applications of CMC when blended with other polymeric compounds such as cellulose, starch, alginate, chitosan, and polylactic acid to overcome these limitations. Blending enhances tensile strength, water resistance, and antimicrobial functionality, extends food shelf life, and reduces reliance on synthetic plastics. Nanocomposite techniques and bioactive molecule incorporation further improve film performance. Innovative processing methods, including electrospinning and three-dimensional printing, offer new opportunities for structural enhancement. This literature review aims to assess key challenges, including material compatibility, processing efficiency, scalability, and environmental sustainability. CMC-based films, especially in composite formulations, show significant promise in advancing sustainable food packaging. However, for widespread industrial adoption, optimized formulations and ecoefficient production techniques are essential.
BMC Nursing · vol. 24 (1) · 367-367
BACKGROUND: Nurses in neonatal intensive care units face critical challenges in managing emergencies where timely, accurate interventions are essential for survival. Traditional nursing education often lacks the hands-on, immersive training required to build complex emergency skills, contributing to persistent neonatal mortality globally. Virtual reality (VR) simulation, grounded in Kolb's Experiential Learning Theory, offers a promising solution by replicating realistic and repeatable clinical scenarios. While VR has shown potential in nursing education, its specific impact on high-risk neonatal emergencies remains underexplored. AIM: To evaluate the effectiveness of a VR simulation program in enhancing nurse competency and improving neonatal outcomes during emergency care, grounded in Kolb's Experiential Learning Theory. METHODS: A concurrent triangulation mixed-methods design was implemented over two weeks across four pediatric hospitals. Through stratified random sampling, 128 NICU nurses were allocated to VR simulation (n = 64) or traditional training (n = 64) groups. Quantitative data were collected using validated instruments (OSCE: CVI = 0.92, MCQ: α = 0.86) measuring clinical skills, knowledge retention, and decision-making accuracy. Qualitative data were gathered through semi-structured interviews (n = 24) exploring experiential aspects. RESULTS: The VR group showed significant improvements in clinical skills (OSCE: +16.1 points, p < 0.001, d = 1.58), decision-making accuracy (+ 16.7%, p < 0.001), and reduced stabilization times (-6.2 min, p < 0.001). Patient safety events decreased by 52% (p < 0.001). Thematic analysis revealed enhanced professional competence (83%), reduced clinical anxiety (75%), and positive learning experiences (88%), despite minor technical challenges. CONCLUSION: VR simulation demonstrates superior effectiveness for neonatal emergency training, significantly improving both nurse competency and patient outcomes. While geographic specificity and brief follow-up duration limit generalizability, findings support VR's potential for enhancing emergency preparedness. Future research should address longitudinal outcomes and implementation across diverse healthcare settings. CLINICAL TRIAL NUMBER: Not applicable.
Scientific Reports · vol. 15 (1) · 7589-7589
The healthcare industry, aided by technology, leverages the Internet of Things (IoT) paradigm to offer patient/user-related services that are ubiquitous and personalized. The authorized repository stores ubiquitous data for which access-level securities are granted. These security measures ensure that only authorized entities can access patient/user health information, preventing unauthorized entries and data downloads. However, recent sophisticated security and privacy attacks such as data breaches, data integrity issues, and data collusion have raised concerns in the healthcare industry. As healthcare data grows, conventional solutions often fail due to scalability concerns, causing inefficiencies and delays. This is especially true for multi-key authentication. Dependence on conventional access control systems leads to security flaws and authorization errors caused by static user behaviour models. This article introduces an Opportunistic Access Control Scheme (OACS) for leveraging access-level security. This approach is a defendable access control scheme in which the user permissions are based on their requirement and data. After accessing the healthcare record, a centralized IoT security augmentation and assessment is provided. The blockchain records determine and revoke the access grant based on previous access and delegation sequences. This scheme analyses the possible delegation methods for providing precise users with interrupt-free healthcare record access. The blockchain recommendations are analyzed using a trained learning paradigm to provide further access and denials. The proposed method reduces false rates by 11.74%, increases access rates by 13.1%, speeds up access and processing by 12.36% and 13.23%, respectively, and reduces failure rates by 9.94%. The OACS decreases false rates by 10.64%, processing time by 15.62%, and failure rates by 10.95%.